CLINICAL_TRIALS
trial_result
· 2016-11-09
Clinical Trial Update: Brilinta DaYu Study [Phase 4]
Summary
Phase 4 trial update for Brilinta (ticagrelor) in acute coronary syndrome; the study has completed and results were posted on 2016-11-09.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Acute Coronary Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2016-11-09